557
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Outpatients’ Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 3621-3632 | Published online: 31 Dec 2021

References

  • Ministry of Health, Social Services and Equality. Government of Spain. Royal Legislative Decree 1/2015, of July 24, approving the revised text of the Law on guarantees and rational use of medicines and health products. “BOE” no. 177, of July 25, 2015. Reference: BOE-A-2015-8343. Available from: https://www.boe.es/buscar/pdf/2015/BOE-A-2015-8343-consolidado.pdf. Accessed December 17, 2021.
  • Margusino-Framiñán L, Cid-Silva P, Martínez-Roca C, et al. Implementation of Specialized Pharmaceutical Care Hospital Outpatient Clinics in a Hospital Pharmacy Department. Farm Hosp. 2017;41:660–666. doi:10.7399/fh.10771
  • Spanish Society of Hospital Pharmacy. Outpatient Pharmaceutical Care Strategic Map. MAPEX project. Available from: https://www.sefh.es/mapex/index.php/documentacion. Accessed December 17, 2021.
  • Morillo-Verdugo R, Calleja-Hernández MÁ, Robustillo-Cortés MLA, Poveda-Andrés JL. A new definition and refocus of pharmaceutical care: the Barbate Document. Farm Hosp. 2020;44:158–162. doi:10.7399/fh.11389
  • World Health Organization. WHO Library. Telemedicine. Opportunities and Developments in Members States. Geneva (Switzerland); 2010. Available from: https://www.who.int/goe/publications/goe_telemedicine_2010.pdf. Accessed December 17, 2021.
  • Alexander E, Butler CD, Darr A, et al. ASHP Statement on Telepharmacy. Am J Health Syst Pharm. 2017:74236–74241. doi:10.2146/ajhp170039
  • US National Association of Boards of Pharmacy. Telepharmacy: the new frontier of patient care and professional practice. Mount Prospect (Illinois, EEUU); 2017. Available from: https://nabp.pharmacy/wp-content/uploads/2016/07/Innovations_June_July_Final.pdf. Accessed December 17, 2021.
  • Canadian Society of Hospital Pharmacist. Telepharmacy Guidelines. Ottawa (Canada); 2017. Available from: https://www.telemedecine-360.com/wp-content/uploads/2019/03/2018-CSHP-Telepharmacy-Guidelines.pdf. Accessed December 17, 2021.
  • Morillo-Verdugo R, Margusino-Framiñán L, Monte-Boquet E, et al. Spanish Society of Hospital Pharmacy Position Statement on Telepharmacy: recommendations for its implementation and development. Farm Hosp. 2020;44:174–181. doi:10.7399/fh.11515
  • Order SND/293/2020, of March 25, which establishes conditions for the dispensing and administration of medicines within the scope of the National Health System, in the face of the health crisis caused by COVID-19. Official State Gazette No. 85 (March 27, 2020). Available at: https://www.boe.es/boe/dias/2020/03/27/pdfs/BOE-A-2020-4130.pdf. Accessed December 17, 2021.
  • Margusino-Framiñán L, Illarro-Uranga A, Lorenzo-Lorenzo K, et al. Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy. Farm Hosp. 2020;44:61–65. doi:10.7399/fh.11498
  • Tortajada-Goitia B, Morillo-Verdugo R, Margusino-Framiñán L, et al. Survey on the situation of telepharmacy as applied to the outpatient care in hospital pharmacy departments in Spain during the COVID-19 pandemic. Farm Hosp. 2020;44:135–140. doi:10.7399/fh.11527
  • Stephane Champely. pwr: basic Functions for Power Analysis. R package version 1.3-0; 2020. https://CRAN.R-project.org/package=pwr. Accessed December 17, 2021.
  • R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. Available from: https://www.R-project.org/. Accessed December 17, 2021.
  • Congiusta S, Solomon P, Conigliaro J, et al. Clinical Quality and Patient Experience in the Adult Ambulatory Setting. Am J Med Qual. 2019;34:87–91. doi:10.1177/1062860618777878
  • Kaźmierczak D, Bogusz-Czerniewicz M. Identification of patient’s requirements in quality management system in health care institutions. Rep Pract Oncol Radiother. 2011;17(1):50–53. doi:10.1016/j.rpor.2011.10.006
  • Rodríguez-González CG, Sarobe-González C, Durán-García ME, et al. Use of the EFQM excellence model to improve hospital pharmacy performance. Res Social Adm Pharm. 2020;16:710–716. doi:10.1016/j.sapharm.2019.08.030
  • The Joint Commission. Evaluating Patient’s Perception of Care and Program Effectiveness – options. Available from: https://www.jointcommission.org/standards/standard-faqs/advanced-dsc—comprehensive-stroke/performance-measurement-dspm/000001611/. Accessed December 23, 2021.
  • Kluetz PG, O’Connor DJ, Soltys K. Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada. Lancet Oncol. 2018;19:e267–e274. doi:10.1016/S1470-2045(18)30097-4
  • Kuehn CM. Patient Experience Data in US Food and Drug Administration (FDA) Regulatory Decision Making: a Policy Process Perspective. Ther Innov Regul Sci. 2018;52:661–668. doi:10.1177/2168479017753390
  • Bull C, Byrnes J, Hettiarachchi R, et al. A systematic review of the validity and reliability of patient-reported experience measures. Health Serv Res. 2019;54:1023–1035. doi:10.1111/1475-6773.13187
  • DeRemer CE, Reiter J, Olson JL. Transitioning ambulatory care pharmacy services to telemedicine while maintaining multidisciplinary collaborations. Am J Health Syst Pharm. 2021;78:371–375. doi:10.1093/ajhp/zxaa427
  • Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: a systematic review. Res Social Adm Pharm. 2018;14:707–717. doi:10.1016/j.sapharm.2017.10.011
  • Poudel A, Nissen LM. Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges. Integr Pharm Res Pract. 2016;5:75–82. doi:10.2147/IPRP.S101685
  • Pedersen CA, Schneider PJ, Ganio MC, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2020. Am J Health Syst Pharm. 2021;78:1074-1093. doi:10.1093/ajhp/zxab120
  • Le T, Toscani M, Colaizzi J. Telepharmacy: a New Paradigm for Our Profession. J Pharm Pract. 2020;33:176–182. doi:10.1177/0897190018791060
  • Margusino-Framiñán L, Cid-Silva P, Castro-Iglesias Á, et al. Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: clinical, Economic, and Patient-Perceived Quality Analysis. Telemed J E Health. 2019;25:399–406. doi:10.1089/tmj.2018.0041
  • Rivas MD, Medina RM, Redondo C, et al. Telepharmacy during SARS-COV-2. Eur J Hosp Pharm. 2021;28(Suppl 1):A1–A184.
  • Erku DA, Belachew SA, Abrha S, et al. When fear and misinformation go viral: pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Res Social Adm Pharm. 2021;17:1954–1963. doi:10.1016/j.sapharm.2020.04.032
  • Elson EC, Oermann C, Duehlmeyer S, et al. Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic. Am J Health Syst Pharm. 2020;77:1005–1006. doi:10.1093/ajhp/zxaa112
  • Segal EM, Alwan L, Pitney C, et al. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic. Am J Health Syst Pharm. 2020;77:1403–1408. doi:10.1093/ajhp/zxaa184
  • Ameri A, Salmanizadeh F, Bahaadinbeigy K. Tele-pharmacy: a new opportunity for consultation during the COVID-19 pandemic. Health Policy Technol. 2020;9:281–282. doi:10.1016/j.hlpt.2020.06.005
  • Li H, Zheng S, Liu W, et al. Fighting against COVID-19: innovative strategies for clinical pharmacist. Res Social Adm Phar. 2021;17:1813–1818. doi:10.1016/j.sapharm.2020.04.003
  • Nittari G, Khuman R, Baldoni S, et al. Telemedicine Practice: review of the Current Ethical and Legal Challenges. Telemed J E Health. 2020;26:1427–1437. doi:10.1089/tmj.2019.0158
  • Angaran DM. Telemedicine and telepharmacy: current status and future implications. Am J Health Syst Pharm. 1999;56:1405–1426. doi:10.1093/ajhp/56.14.1405
  • Daniel H, Sulmasy LS. Health and Public Policy Committee of the American College of Physicians; Policy recommendations to guide the use of telemedicine in primary care settings: an American College of Physicians position paper. Ann Intern Med. 2015;163:787–789. doi:10.7326/M15-0498
  • Martin RD. Levering telecommuting pharmacists in the post-COVID-19 world. J Am Pharm Assoc (2003). 2020;60:e113–e115. doi:10.1016/j.japh.2020.07.026
  • Dorsey ER, Okun MS, Bloem BR. Care, Convenience, Comfort, Confidentiality, and Contagion: the 5 C’s that Will Shape the Future of Telemedicine. J Parkinsons Dis. 2020;10:893–897. doi:10.3233/JPD-202109.
  • Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000;20(3):332–342. doi:10.1177/0272989X0002000310
  • King JT, Tsevat J, Lave JR, et al. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making. 2005;25:667–677. doi:10.1177/0272989X05282640.
  • Yap KY, Low HX, Koh KS, et al. A Feasibility and acceptance of a pharmacist-run tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients. Telemed J E Health. 2013;19:387–395. doi:10.1089/tmj.2012.0136
  • Vo AT, Gustafson DL. Telepharmacy in oncology care: a scoping review. J Telemed Telecare. 2020;1357633X20975257. doi:10.1177/1357633X20975257
  • Painter JT, Gressler L, Kathe N, et al. Consumer willingness to pay for pharmacy services: an updated review of the literature. Res Social Adm Pharm. 2018;14:1091–1105. doi:10.1016/j.sapharm.2018.01.010